Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Masimo ( (MASI) ) has issued an update.
On February 25, 2025, Masimo announced its financial results for the fourth quarter and full-year 2024, reporting a 9% increase in consolidated revenue for the quarter. The company also provided updated guidance for 2025, highlighting strategic realignment efforts expected to boost earnings and cash flow. The healthcare segment showed strong growth, while the non-healthcare segment experienced a decline. The company plans to classify its Sound United business as ‘held for sale’ and focus on its core healthcare operations.
More about Masimo
Masimo operates in the healthcare industry, specializing in innovative medical technologies. The company focuses on providing solutions for patient care, with a strong emphasis on addressing unmet clinical needs.
YTD Price Performance: 1.28%
Average Trading Volume: 471,774
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $9.14B
For a thorough assessment of MASI stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
- “They Read Like a Cry for Help”, Starbucks Stock (NASDAQ:SBUX) Notches Up Despite Cup Note Concerns
- “The Merger of Marketing and Tech has Never Been Greater”: Home Depot Stock (NYSE:HD) Swings Up With Growing Marketing Plans
- Why Arista Networks Stock (ANET) Is Down Today and Why Morgan Stanley Says ‘Take the Plunge’